The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antacids-Global Market Insights and Sales Trends 2025
Synopsis
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
The global Antacids market size is expected to reach US$ 7843.3 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antacids in various end use industries. The expanding demands from the Rx Drug and OTC Drug, are propelling Antacids market. Non-Systemic Antacids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Systemic Antacids segment is estimated at % CAGR for the next seven-year period.
Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.
In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antacids, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antacids market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antacids market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antacids sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antacids covered in this report include AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter & Gamble, GlaxoSmithKline, Johnson & Johnson and CONBA, etc.
The global Antacids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter & Gamble
GlaxoSmithKline
Johnson & Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Novartis
Global Antacids market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antacids market, Segment by Type:
Non-Systemic Antacids
Systemic Antacids
Global Antacids market, by Application
Rx Drug
OTC Drug
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antacids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antacids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms. Available without a prescription, antacids are available in convenient chewable tablets or as a liquid. Most are relatively inexpensive, making antacids a popular product for fast relief. Antacids are the fastest acting heartburn relief available because they start to weaken the acid in your stomach the second they reach it. The weaker the acid in your stomach, the less likely it is to give you heartburn. The longer an antacid stays in the stomach, the longer it works. And having some food in your stomach may actually prolong an antacid’s effect. Most antacids contain at least one of these key ingredients: calcium carbonate, magnesium hydroxide, aluminum hydroxide and/or sodium bicarbonate.
The global Antacids market size is expected to reach US$ 7843.3 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antacids in various end use industries. The expanding demands from the Rx Drug and OTC Drug, are propelling Antacids market. Non-Systemic Antacids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Systemic Antacids segment is estimated at % CAGR for the next seven-year period.
Global Antacid key players include CONBA, Bayer, Xiuzheng Pharma, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 35%, followed by Europe, and North America, both have a share about 55 percent.
In terms of product, Proton Pump Inhibitor is the largest segment, with a share over 50%. And in terms of application, the largest application is OTC Drug, followed by Rx Drug.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antacids, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antacids market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antacids market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antacids sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antacids covered in this report include AstraZeneca, Takeda Pharmaceutical, Pfizer, Reckitt Benckiser, Bayer, Procter & Gamble, GlaxoSmithKline, Johnson & Johnson and CONBA, etc.
The global Antacids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Takeda Pharmaceutical
Pfizer
Reckitt Benckiser
Bayer
Procter & Gamble
GlaxoSmithKline
Johnson & Johnson
CONBA
Xiuzheng Pharma
Sanofi
Bausch Health
CR SANJIU
Novartis
Global Antacids market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antacids market, Segment by Type:
Non-Systemic Antacids
Systemic Antacids
Global Antacids market, by Application
Rx Drug
OTC Drug
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antacids manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antacids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antacids Market Overview
1.1 Antacids Product Overview
1.2 Antacids Market Segment by Type
1.2.1 Non-Systemic Antacids
1.2.2 Systemic Antacids
1.3 Global Antacids Market Size by Type
1.3.1 Global Antacids Market Size Overview by Type (2018-2029)
1.3.2 Global Antacids Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antacids Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antacids Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antacids Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antacids Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antacids Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antacids Sales Breakdown by Type (2018-2023)
2 Global Antacids Market Competition by Company
2.1 Global Top Players by Antacids Sales (2018-2023)
2.2 Global Top Players by Antacids Revenue (2018-2023)
2.3 Global Top Players by Antacids Price (2018-2023)
2.4 Global Top Manufacturers Antacids Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antacids Market Competitive Situation and Trends
2.5.1 Antacids Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antacids Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antacids as of 2022)
2.7 Date of Key Manufacturers Enter into Antacids Market
2.8 Key Manufacturers Antacids Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antacids Status and Outlook by Region
3.1 Global Antacids Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antacids Historic Market Size by Region
3.2.1 Global Antacids Sales in Volume by Region (2018-2023)
3.2.2 Global Antacids Sales in Value by Region (2018-2023)
3.2.3 Global Antacids Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antacids Forecasted Market Size by Region
3.3.1 Global Antacids Sales in Volume by Region (2024-2029)
3.3.2 Global Antacids Sales in Value by Region (2024-2029)
3.3.3 Global Antacids Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antacids by Application
4.1 Antacids Market Segment by Application
4.1.1 Rx Drug
4.1.2 OTC Drug
4.2 Global Antacids Market Size by Application
4.2.1 Global Antacids Market Size Overview by Application (2018-2029)
4.2.2 Global Antacids Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antacids Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antacids Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antacids Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antacids Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antacids Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antacids Sales Breakdown by Application (2018-2023)
5 North America Antacids by Country
5.1 North America Antacids Historic Market Size by Country
5.1.1 North America Antacids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antacids Sales in Volume by Country (2018-2023)
5.1.3 North America Antacids Sales in Value by Country (2018-2023)
5.2 North America Antacids Forecasted Market Size by Country
5.2.1 North America Antacids Sales in Volume by Country (2024-2029)
5.2.2 North America Antacids Sales in Value by Country (2024-2029)
6 Europe Antacids by Country
6.1 Europe Antacids Historic Market Size by Country
6.1.1 Europe Antacids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antacids Sales in Volume by Country (2018-2023)
6.1.3 Europe Antacids Sales in Value by Country (2018-2023)
6.2 Europe Antacids Forecasted Market Size by Country
6.2.1 Europe Antacids Sales in Volume by Country (2024-2029)
6.2.2 Europe Antacids Sales in Value by Country (2024-2029)
7 Asia-Pacific Antacids by Region
7.1 Asia-Pacific Antacids Historic Market Size by Region
7.1.1 Asia-Pacific Antacids Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antacids Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antacids Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antacids Forecasted Market Size by Region
7.2.1 Asia-Pacific Antacids Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antacids Sales in Value by Region (2024-2029)
8 Latin America Antacids by Country
8.1 Latin America Antacids Historic Market Size by Country
8.1.1 Latin America Antacids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antacids Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antacids Sales in Value by Country (2018-2023)
8.2 Latin America Antacids Forecasted Market Size by Country
8.2.1 Latin America Antacids Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antacids Sales in Value by Country (2024-2029)
9 Middle East and Africa Antacids by Country
9.1 Middle East and Africa Antacids Historic Market Size by Country
9.1.1 Middle East and Africa Antacids Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antacids Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antacids Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antacids Forecasted Market Size by Country
9.2.1 Middle East and Africa Antacids Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antacids Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Antacids Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Antacids Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Takeda Pharmaceutical
10.2.1 Takeda Pharmaceutical Company Information
10.2.2 Takeda Pharmaceutical Introduction and Business Overview
10.2.3 Takeda Pharmaceutical Antacids Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Takeda Pharmaceutical Antacids Products Offered
10.2.5 Takeda Pharmaceutical Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Antacids Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Antacids Products Offered
10.3.5 Pfizer Recent Development
10.4 Reckitt Benckiser
10.4.1 Reckitt Benckiser Company Information
10.4.2 Reckitt Benckiser Introduction and Business Overview
10.4.3 Reckitt Benckiser Antacids Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Reckitt Benckiser Antacids Products Offered
10.4.5 Reckitt Benckiser Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer Antacids Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bayer Antacids Products Offered
10.5.5 Bayer Recent Development
10.6 Procter & Gamble
10.6.1 Procter & Gamble Company Information
10.6.2 Procter & Gamble Introduction and Business Overview
10.6.3 Procter & Gamble Antacids Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Procter & Gamble Antacids Products Offered
10.6.5 Procter & Gamble Recent Development
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Company Information
10.7.2 GlaxoSmithKline Introduction and Business Overview
10.7.3 GlaxoSmithKline Antacids Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GlaxoSmithKline Antacids Products Offered
10.7.5 GlaxoSmithKline Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Information
10.8.2 Johnson & Johnson Introduction and Business Overview
10.8.3 Johnson & Johnson Antacids Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Johnson & Johnson Antacids Products Offered
10.8.5 Johnson & Johnson Recent Development
10.9 CONBA
10.9.1 CONBA Company Information
10.9.2 CONBA Introduction and Business Overview
10.9.3 CONBA Antacids Sales, Revenue and Gross Margin (2018-2023)
10.9.4 CONBA Antacids Products Offered
10.9.5 CONBA Recent Development
10.10 Xiuzheng Pharma
10.10.1 Xiuzheng Pharma Company Information
10.10.2 Xiuzheng Pharma Introduction and Business Overview
10.10.3 Xiuzheng Pharma Antacids Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Xiuzheng Pharma Antacids Products Offered
10.10.5 Xiuzheng Pharma Recent Development
10.11 Sanofi
10.11.1 Sanofi Company Information
10.11.2 Sanofi Introduction and Business Overview
10.11.3 Sanofi Antacids Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Sanofi Antacids Products Offered
10.11.5 Sanofi Recent Development
10.12 Bausch Health
10.12.1 Bausch Health Company Information
10.12.2 Bausch Health Introduction and Business Overview
10.12.3 Bausch Health Antacids Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bausch Health Antacids Products Offered
10.12.5 Bausch Health Recent Development
10.13 CR SANJIU
10.13.1 CR SANJIU Company Information
10.13.2 CR SANJIU Introduction and Business Overview
10.13.3 CR SANJIU Antacids Sales, Revenue and Gross Margin (2018-2023)
10.13.4 CR SANJIU Antacids Products Offered
10.13.5 CR SANJIU Recent Development
10.14 Novartis
10.14.1 Novartis Company Information
10.14.2 Novartis Introduction and Business Overview
10.14.3 Novartis Antacids Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Novartis Antacids Products Offered
10.14.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antacids Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antacids Industrial Chain Analysis
11.4 Antacids Market Dynamics
11.4.1 Antacids Industry Trends
11.4.2 Antacids Market Drivers
11.4.3 Antacids Market Challenges
11.4.4 Antacids Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antacids Distributors
12.3 Antacids Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
